Project Details
Description
The Diverse Epigenetic Epidemiology Partnership (DEEP) is a partnership of 20 research groups from around the world that aims to improve global health by exploring the effects of genomic and environmental diversity on disease risk across the global population.
DEEP study researchers are interested in studying the differences in disease mechanism and disease risk prediction that are associated with DNA methylation. DNA methylation refers to modifications to DNA which help in turning genes on or off (transcription).The DEEP study ultimately aims to identify disease mechanisms and drug targets that work for all.
https://www.deep-epigenetics.org/
DEEP study researchers are interested in studying the differences in disease mechanism and disease risk prediction that are associated with DNA methylation. DNA methylation refers to modifications to DNA which help in turning genes on or off (transcription).The DEEP study ultimately aims to identify disease mechanisms and drug targets that work for all.
https://www.deep-epigenetics.org/
| Alternative title | Diverse Epigenetic Epidemiology Partnership |
|---|---|
| Acronym | DEEP study |
| Status | Active |
| Effective start/end date | 1/10/23 → 30/09/28 |
| Links | http://www.deep-epigenetics.org |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.